Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18076805rdf:typepubmed:Citationlld:pubmed
pubmed-article:18076805lifeskim:mentionsumls-concept:C0684224lld:lifeskim
pubmed-article:18076805lifeskim:mentionsumls-concept:C0278488lld:lifeskim
pubmed-article:18076805lifeskim:mentionsumls-concept:C0600688lld:lifeskim
pubmed-article:18076805lifeskim:mentionsumls-concept:C0078257lld:lifeskim
pubmed-article:18076805lifeskim:mentionsumls-concept:C0045093lld:lifeskim
pubmed-article:18076805lifeskim:mentionsumls-concept:C0868928lld:lifeskim
pubmed-article:18076805lifeskim:mentionsumls-concept:C0205195lld:lifeskim
pubmed-article:18076805pubmed:issue12lld:pubmed
pubmed-article:18076805pubmed:dateCreated2007-12-13lld:pubmed
pubmed-article:18076805pubmed:abstractTextChemotherapy is one of major treatments of metastatic breast cancer. Anthracyclines and taxanes are usually considered as the most active agents in breast cancer and are often used as adjuvant or first-line therapy. Gemcitabine and vinorelbine are active agents in breast cancer. This study was to evaluate the efficacy of gemcitabine combined vinorelbine on the patients with metastatic breast cancer, who had previously received treatment of anthracyclines and/or taxanes.lld:pubmed
pubmed-article:18076805pubmed:languagechilld:pubmed
pubmed-article:18076805pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18076805pubmed:citationSubsetIMlld:pubmed
pubmed-article:18076805pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18076805pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18076805pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18076805pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18076805pubmed:statusMEDLINElld:pubmed
pubmed-article:18076805pubmed:monthDeclld:pubmed
pubmed-article:18076805pubmed:issn1000-467Xlld:pubmed
pubmed-article:18076805pubmed:authorpubmed-author:JiangWen-QiWQlld:pubmed
pubmed-article:18076805pubmed:authorpubmed-author:LiuDong-GengD...lld:pubmed
pubmed-article:18076805pubmed:authorpubmed-author:TengXiao-YuXYlld:pubmed
pubmed-article:18076805pubmed:authorpubmed-author:ZhouNing-Ning...lld:pubmed
pubmed-article:18076805pubmed:issnTypePrintlld:pubmed
pubmed-article:18076805pubmed:volume26lld:pubmed
pubmed-article:18076805pubmed:ownerNLMlld:pubmed
pubmed-article:18076805pubmed:authorsCompleteYlld:pubmed
pubmed-article:18076805pubmed:pagination1373-6lld:pubmed
pubmed-article:18076805pubmed:meshHeadingpubmed-meshheading:18076805...lld:pubmed
pubmed-article:18076805pubmed:meshHeadingpubmed-meshheading:18076805...lld:pubmed
pubmed-article:18076805pubmed:meshHeadingpubmed-meshheading:18076805...lld:pubmed
pubmed-article:18076805pubmed:meshHeadingpubmed-meshheading:18076805...lld:pubmed
pubmed-article:18076805pubmed:meshHeadingpubmed-meshheading:18076805...lld:pubmed
pubmed-article:18076805pubmed:meshHeadingpubmed-meshheading:18076805...lld:pubmed
pubmed-article:18076805pubmed:meshHeadingpubmed-meshheading:18076805...lld:pubmed
pubmed-article:18076805pubmed:meshHeadingpubmed-meshheading:18076805...lld:pubmed
pubmed-article:18076805pubmed:meshHeadingpubmed-meshheading:18076805...lld:pubmed
pubmed-article:18076805pubmed:meshHeadingpubmed-meshheading:18076805...lld:pubmed
pubmed-article:18076805pubmed:meshHeadingpubmed-meshheading:18076805...lld:pubmed
pubmed-article:18076805pubmed:meshHeadingpubmed-meshheading:18076805...lld:pubmed
pubmed-article:18076805pubmed:meshHeadingpubmed-meshheading:18076805...lld:pubmed
pubmed-article:18076805pubmed:meshHeadingpubmed-meshheading:18076805...lld:pubmed
pubmed-article:18076805pubmed:meshHeadingpubmed-meshheading:18076805...lld:pubmed
pubmed-article:18076805pubmed:meshHeadingpubmed-meshheading:18076805...lld:pubmed
pubmed-article:18076805pubmed:meshHeadingpubmed-meshheading:18076805...lld:pubmed
pubmed-article:18076805pubmed:meshHeadingpubmed-meshheading:18076805...lld:pubmed
pubmed-article:18076805pubmed:year2007lld:pubmed
pubmed-article:18076805pubmed:articleTitle[Efficacy and toxicity of gemcitabine combined vinorelbine on metastatic breast cancer: a report of 34 cases].lld:pubmed
pubmed-article:18076805pubmed:affiliationState Key Laboratory of Oncology in South China, Guangzhou, Guangdong, 510060, PR China.lld:pubmed
pubmed-article:18076805pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:18076805pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:18076805pubmed:publicationTypeEnglish Abstractlld:pubmed